Macrophage-Colony-Stimulating Factor Receptor Enhances Prostate Cancer Cell Growth and Aggressiveness In Vitro and In Vivo and Increases Osteopontin Expression

Archive ouverte

Mougel, Alexandra | Adriaenssens, Eric | Guyot, Boris | Tian, Lu | Gobert, Stéphanie | Chassat, Thierry | Persoons, Philippe | Hannebique, David | Bauderlique-Le Roy, Hélène | Vicogne, Jérôme | Le Bourhis, Xuefen | Bourette, Roland, P

Edité par CCSD ; MDPI -

International audience. Prostate cancer is a major public health concern and one of the most prevalent forms of cancer worldwide. The definition of altered signaling pathways implicated in this complex disease is thus essential. In this context, abnormal expression of the receptor of Macrophage Colony-Stimulating Factor-1 (M-CSF or CSF-1) has been described in prostate cancer cells. Yet, outcomes of this expression remain unknown. Using mouse and human prostate cancer cell lines, this study has investigated the functionality of the wild-type CSF-1 receptor in prostate tumor cells and identified molecular mechanisms underlying its ligand-induced activation. Here, we showed that upon CSF-1 binding, the receptor autophosphorylates and activates multiple signaling pathways in prostate tumor cells. Biological experiments demonstrated that the CSF-1R/CSF-1 axis conferred significant advantages in cell growth and cell invasion in vitro. Mouse xenograft experiments showed that CSF-1R expression promoted the aggressiveness of prostate tumor cells. In particular, we demonstrated that the ligandactivated CSF-1R increased the expression of spp1 transcript encoding for osteopontin, a key player in cancer development and metastasis. Therefore, this study highlights that the CSF-1 receptor is fully functional in a prostate cancer cell and may be a potential therapeutic target for the treatment of prostate cancer.

Suggestions

Du même auteur

s-SHIP Promoter Expression Identifies Mouse Mammary Cancer Stem Cells

Archive ouverte | Tian, Lu | CCSD

International audience. During normal mammary gland development, s-SHIP promoter expression marks a distinct type of mammary stem cells, at two different stages, puberty and early mid-pregnancy. To determine whether...

s-SHIP Promoter Expression Identifies Mouse Mammary Cancer Stem Cells. L'expression de s-SHIP identifie une population de cellules souches cancéreuses chez la souris

Archive ouverte | Tian, Lu | CCSD

International audience

2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations

Archive ouverte | Trzaska, Carole | CCSD

International audience. Nonsense mutations cause about 10% of genetic disease cases, and no treatments are available. Nonsense mutations can be corrected by molecules with nonsense mutation readthrough activity. An ...

Chargement des enrichissements...